Prescribing Reference · Female Patient

Topical Testosterone Gel / Female Dosing

A clinical reference for prescribing 1% testosterone gel in female patients, including dosing math, syringe-titration technique, application guidance, and expected adverse-event profile.

Prescription

℞ Testosterone Gel 1% — single-use packets Equivalent strength to AndroGel 1% packets (50 mg testosterone per 5 g packet)

Sig

Apply 0.5 mL (≈ 5 mg testosterone) topically once daily to clean, dry skin of the outer thigh, glute, or lower abdomen. Avoid chest, neck, and face. Wash hands after application. Allow to dry fully before any skin contact with another person.

Dispense

30 packets (one-month supply)

Refills

Notes

Female off-label dosing. Titrate per Section 3 below. Reassess clinically and biochemically at 8–12 weeks before refill.

Prescriber: Steven Sorr, NMD Source of Health · 480.361.4005

1 · Dosing Math & Measurement

Most commercial 1% testosterone gels deliver:

Concentration Reference

50 mg testosterone in 5 g gel per packet
≈ 10 mg testosterone per 1 mL gel
0.1 mL ≈ 1 mg | 0.5 mL ≈ 5 mg

Syringe-Notch Technique

Empty packet into a small sterile medication jar (or directly into a 1 mL syringe).
Use a 1 mL Luer-slip syringe with no needle attached.
Draw to the prescribed mark (the "notch") and dispense daily onto the application site.

The "push to the notch" concept typically refers to using the 0.3–0.5 mL graduation on a 1 mL syringe for repeatable, low-variance daily dosing.

2 · Typical Female Dosing Range

Daily Dose	Volume	Indication / Tier
2.5 mg / day	0.25 mL	Conservative start; sensitive patients, low SHBG, prior androgen exposure
5 mg / day	0.50 mL	Standard female maintenance dose
7.5 – 10 mg / day	0.75 – 1.0 mL	Select patients only; high SHBG, refractory libido, supervised escalation

Titration Rule

Start low. Adjust every 8–12 weeks based on symptoms, free testosterone, and SHBG — not on total testosterone alone. Women are far more sensitive to incremental dose changes than men.

3 · Clinical Pearls

Sensitivity Women respond to dose changes at a fraction of male thresholds. Half-step adjustments (0.1 mL increments) are clinically meaningful.
Lab Strategy Free testosterone and SHBG are typically more clinically actionable than total testosterone alone. Interpret in the context of symptom response, not numbers in isolation.
Vehicle Matters Alcohol-based commercial gels absorb more aggressively than compounded creams. A patient transitioning between vehicles should expect a change in clinical effect at the same nominal dose.
Lag in Adverse Effects Side effects can emerge months after dose initiation or escalation, not weeks. Track at every visit:
- Acne
- Oily skin
- Hair shedding
- Hirsutism
- Voice deepening (rare · potentially irreversible)
Stop-Point Voice change, clitoromegaly, or progressive androgenic alopecia warrants immediate dose reduction or discontinuation, with re-evaluation of free T and SHBG.

4 · Application Guidance

Apply To

Best sites for systemic absorption with low local DHT conversion.

Outer thigh
Glute
Lower abdomen

Avoid

Higher local DHT conversion or unintended end-organ exposure.

Face, chest, upper back
Vulvar / genital skin (for systemic therapy)
Broken or inflamed skin

Transfer Precautions

Allow application site to dry fully and cover with clothing before contact with partners, children, or pets. Skin-to-skin transfer of testosterone gel has caused virilization in third parties. Patients should be counseled at every visit.